Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,358,000 | 1,508,000 | 1,554,000 | 1,362,000 | 1,412,000 |
| Cost of Goods | 1,094,000 | 1,222,000 | 1,246,000 | 1,078,000 | 1,161,000 |
| Gross Profit | 264,000 | 286,000 | 308,000 | 284,000 | 251,000 |
| Operating Expenses | 204,000 | 267,000 | 183,000 | 169,000 | 256,000 |
| Operating Income | 60,000 | 19,000 | 125,000 | 115,000 | -5,000 |
| Interest Expense | 66,000 | 68,000 | 66,000 | 63,000 | 63,000 |
| Other Income | 5,000 | 17,000 | 10,000 | 18,000 | -3,000 |
| Pre-tax Income | -1,000 | -32,000 | 69,000 | 70,000 | -71,000 |
| Income Tax | 12,000 | N/A | 9,000 | 16,000 | -38,000 |
| Net Income Continuous | -13,000 | -32,000 | 60,000 | 54,000 | -33,000 |
| Net Income | $-13,000 | $-32,000 | $60,000 | $54,000 | $-34,000 |
| EPS Basic Total Ops | -0.08 | -0.22 | 0.40 | 0.36 | -0.23 |
| EPS Basic Continuous Ops | -0.09 | -0.21 | 0.40 | 0.36 | -0.22 |
| EPS Diluted Total Ops | -0.07 | -0.22 | 0.39 | 0.36 | -0.22 |
| EPS Diluted Continuous Ops | -0.09 | -0.21 | 0.40 | 0.36 | -0.21 |
| EPS Diluted Before Non-Recurring Items | 0.11 | 0.40 | 0.38 | N/A | N/A |
| EBITDA(a) | $137,000 | $151,000 | $202,000 | $189,000 | $74,000 |